DTC device ads
This article was originally published in The Gray Sheet
Executive Summary
Extending direct-to-consumer broadcast advertising prescription drug "brief summary" requirements to restricted medical devices likely would "lead to increased advertising...thereby benefiting consumers and competition," according to May 10 1Federal Trade Commission comments to FDA. The proposal initially arose in one of three FDA draft guidances on DTC advertising released in early February (2"The Gray Sheet" Feb. 9, 2004, p. 6)...
You may also be interested in...
Device DTC Guidances Aim To Hone Enforcement, Stimulate Patient Education
FDA's draft guidances for consumer advertising establish explicit standards to which the agency will hold medical device manufacturers accountable, according to Commissioner Mark McClellan
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.